About Aiforia

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful, deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses.

The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields, from oncology to neuroscience and more.

The challenge

Analog tools in a digital world

Pathologists are pivotal to the healthcare system, investigating and diagnosing patient samples to guide medical treatment. Aging populations and rising rates of diseases like cancer are creating a burden on healthcare systems around the world^1. The prevalence of cancer is expected to increase by 47.4% between 2020 and 2040^2, while the share of the population 65 years or over is expected to increase from 9.3% in 2020 to around 16.0% in 2050 globally.

These factors create an additional burden on pathologists, an already underrepresented group of healthcare professionals. Less medical doctors are specializing in pathology⁴ while sample numbers are on the rise, creating an imbalance. Exacerbating this disparity is the fact that pathologists have had to rely on the same technology for the past 150 years⁵; manual slide analysis with microscopes is slow, manual, and prone to variability.

Around the world, pathologists are overworked, patients are waiting for a long time to receive results, and are, in some cases, administered ineffective treatments due to misdiagnosis or the inability to administer personalized treatment. Aiforia believes that the industry is ready for paradigm-shifting technology to decrease the burden experienced by pathologists and patients alike.

Sources
1) WHO Report on Cancer, 2020 PDF Download
2) International Agency for Research on Cancer
3) United Nations Department of Economic and Social Affairs, Population Division (2020). World Population Ageing 2020 Highlights: Living arrangements of older persons
4) Wang et al. Journal of the American Academy of Dermatology. 2018;78(1):47-53
5) The Royal college of pathologists: Histopathology workforce census 17/18
6) Market Intellix and Maia Research: Global Microscope Slide Market Report 2021

Same technology for the past 150 years

Our solution

AI-assisted analysis

Aiforia believes that automation, digital technology, and AI are in growing demand to alleviate the challenges faced by global healthcare systems. AI-based methods have the potential to standardize sample review by reducing bias while increasing the speed and accuracy of analysis — assisting the pathologist in their work and enabling precision diagnostics. Patients can receive diagnoses faster, are administered personalized treatments, and patient care is democratized.

Automation, digital technology and AI

Our mission

Data-driven healthcare

Aiforia’s mission is to provide global access to AI-powered image analysis to be used by healthcare professionals and researchers within a broad spectrum of fields.

Our tools will improve their workflow efficiency and scalability — enabling new discoveries, better-informed decisions, and more personalized patient care.

Around the world, pathologists are overworked, patients are waiting for a long time to receive results, and are, in some cases, administered ineffective treatments due to misdiagnosis or the inability to provide personalized treatment. Aiforia believes that the industry is ready for paradigm-shifting technology to decrease the burden experienced by pathologists and patients alike.

Transform image-based diagnostics

The challenge

Our solution

Our mission

Who are we?